Where should medical device companies go?

Recently, the National Health and Family Planning Commission released the "Progress in China's Disease Prevention and Control (2015)" (hereinafter referred to as the "Report") published at the regular press conference, reviewing the progress of disease prevention and control in China in the past decade. to sum up. According to the report, chronic diseases, as a non-communicable disease, have the highest mortality rate in the country.

With the acceleration of China's aging population and the deterioration of the global environment, the number of people suffering from chronic diseases worldwide has increased dramatically. It is learned that in China, the incidence of hypertension is about 30%, the number of high blood pressure people in the country is close to 200 million, and the number of people with diabetes is more than 100 million. This huge group of chronic diseases brings a heavy burden to the society, and hypertension causes stroke and other heart. Cerebrovascular disease is a serious threat to human health, and the complications caused by diabetes are also the main cause of death. These chronic diseases require medical investment, and the development speed of medical devices as the basic equipment for diagnosis and treatment must also be improved. Numerous manufacturers have also targeted this vast market, and medical diagnostic equipment for chronic diseases has been favored by the market.

“According to changes in disease spectrum, we will speed up the construction of a chronic disease prevention and control system, and initially establish a comprehensive detection system covering the causes of death of residents, extremely dangerous factors of chronic diseases, follow-up registration of tumors, and nutritional status of residents.” Yu Jing, Director of the National Health and Family Planning Commission Into the expression.

According to two types of multiple diseases such as hypertension, the industry speculates that medical devices are expected to achieve key development in four aspects. One is the field of cardiac stents. Cardiovascular diseases cause great stress on the heart and are most likely to cause heart disease. The heart stent has a great slowing effect on the disease, and it is an ideal treatment method at present, and it is more and more widely used in the medical field. China's development in the field of cardiac stents is not bad, the level is close to the international level, and it is expected that imports will be gradually replaced in the future, and its development prospects are more optimistic. The second is a cardiac pacemaker, which is also a commonly used medical device for treating heart diseases. At present, China's market in this field is also monopolized by foreign companies, and domestic products only occupy a small share, but with the encouragement of the state is expected to rise. the amount.

The third is the field of preventive testing. This aspect is mainly aimed at diabetes. The future demand for in vitro diagnostic coherence equipment and testing reagents is very large. Not only in diabetes, but also in other medical fields, it is expected that there will be much room for development. Such as POCT, on-site rapid detection, is an emerging segment of in vitro diagnostics. This term sounds strange, but everyone is familiar with the blood glucose meter. At present, POCT can detect multiple indicators, including blood sugar, blood gas/electrolyte, blood coagulation, cardiac/tumor markers, and drug/alcohol testing. With the continuous introduction of immunochromatography, colloidal gold technology, electroluminescence, time-resolved fluorescence technology, biosensor technology and biochip technology, the development of POCT has also gained a strong pillar.

Finally, wearable devices, combined with big data analysis, through continuous medical monitoring data, can not only provide early warning of the disease, but also provide users with recommendations for care, such as the best timing of medication, how to use exercise and sleep to stabilize the disease, etc. Wait. At present, China is in a period of high incidence of chronic diseases. The number of people, high cost and large demand have become the characteristics of this period, which has indirectly caused disputes between doctors and patients. Real-time data monitoring of wearable medical devices allows patients to rationally regulate their diet and exercise at home, reducing the number of visits and hospitalization.

The increase in the incidence of chronic diseases will bring opportunities for the development of medical devices. Together with the support of national policies, this will greatly release the potential of the medical device market. The medical machinery industry is bound to develop at a faster rate. In the market for chronic disease diagnostic equipment, real competition has just begun.

YT-H008

YT-H008

YT-H008

Shenzhen Sunshine Technology Co.,Ltd , https://www.shenzhenyatwin.com